News
Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...
Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the ...
Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in ...
Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...
The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...
The animal health division of global pharmaceutical company Merck is doubling down on its operations in De Soto.
To keep up with growing demand, Merck Animal Health will invest nearly $900 million to expand its manufacturing facility in ...
About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest ...
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results